This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Job titles for Cannabis Regulator and Trainee positions are approved.
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. The Medical Cannabis Advisory Board (MCAB) convened four times in FY24.
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Increase public outreach with the industry, newcomers to cannabis, advocacy groups, and the general public.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Federal law enforcement agents and their partners made fewer marijuana-related arrests in 2019, but seized a far greater number of plants than they did the year before, according to annual data compiled by US Drug Enforcement Administration. The program rapidly expanded to include programs in 25 states by 1982. million in 2018.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. In 2018 there were nearly 24,000 adults arrested for less than 30 grams of cannabis. cannabis arrest data since 2008.
The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. The annual revenues related to medical cannabis now total more than the total revenues generated by the sales of blueberries, maple syrup, apples, herring, and oysters combined.
physicians “from completing forms or registering veterans for participation in state-approved [medical marijuana] program[s].” Emerging evidence indicates that cannabis can potentially mitigate many of the symptoms plaguing our nation’s veterans. Department of Veterans Affairs explicitly prohibits V.A.
Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse.
Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. What could the implications be for patients on their medical cannabis journey? Rescheduling would stand to have the largest impact on cannabis research and business taxes.
More than six in ten registered voters say that they intend to vote for a statewide ballot measure this November to legalize the adult-use cannabis market, according to polling data compiled by Monmouth University. Only adults at least 21 years of age could use cannabis. Cannabis products would be subject to the State sales tax.
"At a time when voters and their elected officials nationwide are re-evaluating state and federal marijuana policies, it is inconceivable that government agencies are unwilling to provide data on the estimated costs and scope of federal marijuana prohibition in America."
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
When it comes to buying a cannabis enthusiast’s home, the resale value research is less clear, though 30% of realtors say they have struggled to sell a house where cannabis was grown. Legal cannabis raises home value. There’s been a lot of chatter surrounding cannabis and the real estate market.
The Coalition letter focuses on the need for small business access to the SBA relief funds as an avenue to protect the progress that has been made by minority entrepreneurs in the emerging legal cannabis marketplaces. You can read NORML’s factsheet on the racial disparity among arrests here. You can read the full letter below.
Starting this week, the Cannabis Control Commission (Commission)’s Open Data Platform composed of application and license, agent registration and ownership, and sales and product distribution information is now available on their main website at. MassCannabisControl.com/open- data. View the Open Data Platform.
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”
Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment. and the U.S. and the U.S.
Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.
The enactment of adult-use marijuana legalization laws is not associated with any significant increase in cannabis-related activity in neighboring states and counties, according to a federally funded report published by the nonprofit Justice Research and Statistics Association and first reported by MarijuanaMoment.net.
The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
The Changing Landscape of Me dical Marijuana in Massachusetts: What Patients Should Know The Massachusetts medical marijuana program has been a cornerstone of cannabis access since its inception in 2012. MPAA) the states leading voice for patient rights and cannabis policy reform. decrease from peak enrollment.
Akerna (Nasdaq: KERN ), an enterprise software, leading compliance technology provider, and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform ® ), announced a new offering, Akerna Connect. In addition, consumers can opt-in for loyalty programs and text message alerts.
Ottawa has lost control of veterans’ medical marijuana program, audit finds. Audit of Health Care Benefits – Cannabis For Medical Purposes. Collection of data and trends to inform policy. And that number is expected to grow to $200 million this year and $300 million by 2025-26. Read full report. April 2022.
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California.
16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Logo : Santé Cannabis and Spectrum Therapeutics, the medical division of Canopy Growth (CNW Group/Canopy Growth Corporation). MONTREAL and SMITHS FALLS, ON, Sept.
Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.
“Senate Bill 420 is another sign that the growing public support for ending our failed war on cannabis consumers nationwide is continuing to translate into political support amongst federal officials,” said NORML Political Director Justin Strekal. Click here to send a message to your lawmakers in support of Senate Bill 420 now!
“This critical effort works to correct that injustice by providing $100 million toward expungement programs and creating an investment fund for people of color and female entrepreneurs who wish to enter the lucrative legal cannabis industry.” Thirty-three states, Washington, D.C. and the U.S.
Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The full ASCO meeting program is available at: www.asco.org. NEW YORK , June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. About AIkido Pharma Inc.
Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. He continued: “The fact of the matter is that legalization and regulation work.
The rulemaking provisions are meant to better define “academic research institutions that are eligible to participate in the industrial hemp program as institutions that offer agricultural programs or degrees; offer in-person programs at a physical location in Illinois; are Illinois non-profit entities; and conduct research on hemp.
First off, I want to thank you for being an active member of the cannabis reform movement and I am proud to tell you that we have never been closer to ending the counterproductive and cruel policy of marijuana criminalization than we are right now. Congresswoman Barbara Lee represents California’s 13th district.
According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.
The Michigan Marijuana Regulatory Agency (MRA) launched a new program to improve social equity in the state’s cannabis industry. On August 31, the MRA launched the Joint Ventures Pathway Program (JVPP), which is the culmination of an organized discussion that was held earlier this year. . percent were Latino.
The ballot question will read: “Do you approve amending the Constitution to legalize a controlled form of marijuana called ‘cannabis’? Only adults at least 21 years of age could use cannabis. Cannabis products would be subject to the State sales tax. ” Democratic Gov. ” Democratic Gov.
“I’m excited to join the Travelers Institute for a data-driven discussion,” said Wasserman. With new census data, control of Congress on a knife-edge and redistricting just ahead, there couldn’t be a better time to dive into the numbers.”. Programs include: Sept. 22 – “High Risk?
SACRAMENTO – The Bureau of Cannabis Control (Bureau) announced today the launch of a new Application Programming Interface (API). The post BCC Announce New API ” to allow stakeholders to obtain license data that can be integrated into their own software” first appeared on Cannabis Law Report.
Today, we stood with Representatives Tulsi Gabbard and Don Young as they introduced the Ending Federal Prohibition Act and Marijuana Data Collection Act. Currently, ten states and the District of Columbia have legalized the adult use of marijuana and thirty-three states and DC have medical marijuana programs.
Missouri did not launch medical cannabis sales until Oct. 5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program. 5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program. 6, 2019, and Dec. 6, 2019, and Dec.
NORML Political Director Justin Strekal said: “This is a positive step forward to address an untenable tension between state-legal cannabis marketplaces and federal marijuana prohibition. territories of Guam and Puerto Rico have enacted legislation specific to the physician-authorized use of cannabis. and the U.S.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content